青少年子宫附腔畸形临床诊治分析(附1例报告及文献复习)
Clinical Diagnosis and Treatment Analysis of Accessory Cavity Uterine Malformation in Adolescents (with a Case Report and Literature Review)
摘要: 子宫附腔畸形(Accessory Cavitated Uterine Malformation, ACUM)是一种罕见的苗勒管发育异常,主要临床表现为初潮后逐渐加重的痛经,需与囊性子宫腺肌病、子宫肌瘤囊性变及其他阻塞性苗勒管畸形相鉴别。手术是目前主要的治疗方式。本文报告1例青少年女性患者,经期腹痛4年,伴进行性加重2年,需口服止痛药物缓解。2025年1月,妇科B超提示子宫肌瘤,子宫左侧壁结节样回声(1.5 cm × 1.3 cm),考虑为子宫附腔畸形或内膜异位灶。盆腔磁共振成像(Magnetic Resonance Imaging, MRI)检查显示:1. 子宫左侧壁肌层囊性影伴局灶出血,建议结合B超进一步评估;2. 双侧髂血管旁及腹股沟区多发小淋巴结。于经期第2天行腹腔镜探查术,发现盆腔少量积血,无粘连。子宫大小正常,左侧壁圆韧带下方可见一大小约2.0 cm × 1.5 cm × 1.5 cm的凸起,质地稍硬,表面光滑。双侧附件外观未见明显异常。完整切除病变组织并送检,病理检查确诊为ACUM。
Abstract: Accessory Cavitated Uterine Malformation (ACUM) is a rare Müllerian duct anomaly characterized primarily by progressively worsening dysmenorrhea after menarche. It requires differentiation from cystic adenomyosis, cystic degeneration of uterine fibroids, and other obstructive Müllerian duct anomalies. Surgical intervention remains the primary treatment approach. This report details a case involving an adolescent female patient with a 4-year history of menstrual abdominal pain, progressively intensifying over the past 2 years and requiring oral analgesics for symptom control. In January 2025, gynecological ultrasonography indicated a uterine fibroid and revealed a nodular echo (1.5 cm × 1.3 cm) in the left uterine wall, suggestive of either ACUM or an endometriotic lesion. Pelvic Magnetic Resonance Imaging (MRI) demonstrated: 1. A cystic lesion with focal hemorrhage within the left uterine myometrium, warranting further ultrasound evaluation; 2. Multiple small lymph nodes are adjacent to the bilateral iliac vessels and in the inguinal regions. Diagnostic laparoscopy was performed on the second day of menstruation, identifying minimal pelvic hemoperitoneum without adhesions. The uterus exhibited normal dimensions, with a firm, smooth-surfaced protrusion (~2.0 cm × 1.5 cm × 1.5 cm) inferior to the left round ligament. Both adnexa appeared unremarkable. The lesion was completely resected and submitted for histopathological examination, which confirmed ACUM.
文章引用:项义敏, 王媛. 青少年子宫附腔畸形临床诊治分析(附1例报告及文献复习)[J]. 临床医学进展, 2025, 15(8): 1098-1105. https://doi.org/10.12677/acm.2025.1582339

参考文献

[1] 中华医学会妇产科学分会, 中国医师协会妇产科医师分会, 女性生殖道畸形学组. 子宫附腔诊治中国专家共识[J]. 中华妇产科杂志, 2024, 59(9): 657-660.
[2] 曹玉盈, 杨瑾, 周芳竹, 李圃. 子宫附腔的研究进展[J]. 现代妇产科进展, 2024, 33(1): 65-67.
[3] Na, K.Y., Kim, G.Y., Won, K.Y., Kim, H., Kim, S.W., Lee, C.H., et al. (2013) Extrapelvic Uterus-Like Masses Presenting as Colonic Submucosal Tumor: A Case Study and Review of Literature. Korean Journal of Pathology, 47, 177-181. [Google Scholar] [CrossRef] [PubMed]
[4] 中华医学会妇产科学分会, 中国医师协会妇产科医师分会, 女性生殖道畸形学组. 女性生殖器官畸形命名及定义修订的中国专家共识(2022版) [J]. 中华妇产科杂志, 2022, 57(8): 575-580.
[5] Biason-Lauber, A., Konrad, D., Navratil, F. and Schoenle, E.J. (2004) A WNT4 mutation Associated with Müllerian-Duct Regression and Virilization in a 46,XX Woman. New England Journal of Medicine, 351, 792-798. [Google Scholar] [CrossRef] [PubMed]
[6] Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., et al. (2020) FGF/FGFR Signaling in Health and Disease. Signal Transduction and Targeted Therapy, 5, Article No. 181. [Google Scholar] [CrossRef] [PubMed]
[7] 纪菲, 苏娜, 刘华祯, 付子婧, 齐振红, 杨萌. 子宫附腔畸形的超声诊断及误诊原因分析[J]. 协和医学杂志, 2024, 15(5): 1100-1106.
[8] 王铭, 苏娜, 刘真真, 齐振红, 戴晴. 超声对子宫附腔畸形的诊断价值探讨: 附2例报告[J]. 中华超声影像学杂志, 2022, 31(11): 997-999.
[9] 赵子辰, 游燕, 赵佳琳, 朱兰. 子宫附腔6例临床分析及文献复习[J]. 中华妇产科杂志, 2023, 58(11): 850-854.
[10] Allegretti, M., Cesta, M.C., Zippoli, M., Beccari, A., Talarico, C., Mantelli, F., et al. (2021) Repurposing the Estrogen Receptor Modulator Raloxifene to Treat Sars-Cov-2 Infection. Cell Death & Differentiation, 29, 156-166. [Google Scholar] [CrossRef] [PubMed]
[11] Merviel, P., Lelievre, C., Cambier, T., Thomas‐Kergastel, I. and Dupré, P. (2020) The First Ethanol Sclerotherapy of an Accessory Cavitated Uterine Mass. Clinical Case Reports, 9, 19-22. [Google Scholar] [CrossRef] [PubMed]
[12] Ghlichloo, I. and Gerriets, V. (2025) Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). StatPearls Publishing.
http://www.ncbi.nlm.nih.gov/books/NBK547742/
[13] Cooper, D.B. and Patel, P. (2025) Oral Contraceptive Pills. StatPearls Publishing.
http://www.ncbi.nlm.nih.gov/books/NBK430882/
[14] Ali, M., Raslan, M., Ciebiera, M., Zaręba, K. and Al-Hendy, A. (2021) Current Approaches to Overcome the Side Effects of Gnrh Analogs in the Treatment of Patients with Uterine Fibroids. Expert Opinion on Drug Safety, 21, 477-486. [Google Scholar] [CrossRef] [PubMed]
[15] Bao, S., Zhou, T., Yan, C., Bao, J., Yang, F., Chao, S., et al. (2022) A Blood-Based Mirna Signature for Early Non-Invasive Diagnosis of Preeclampsia. BMC Medicine, 20, Article No. 303. [Google Scholar] [CrossRef] [PubMed]
[16] Di Mauro, S., Scamporrino, A., Filippello, A., Di Pino, A., Scicali, R., Malaguarnera, R., et al. (2021) Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. International Journal of Molecular Sciences, 22, Article No. 11905. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, H., Cui, G., Cheng, M., Aji, T., Li, G., Hu, X., et al. (2025) Real‐World Effectiveness and Safety of Oral Azvudine versus Nirmatrelvir-Ritonavir (Paxlovid) in Hospitalized Patients with COVID-19: A Multicenter, Retrospective, Cohort Study. Signal Transduction and Targeted Therapy, 10, Article No. 30. [Google Scholar] [CrossRef] [PubMed]